Formulated siRNAs Targeting Rankl Prevent Osteolysis and Enhance Chemotherapeutic Response in Osteosarcoma Models

Rousseau, J., Escriou, V., Lamoureux, F. et al. (8 more authors) (2011) Formulated siRNAs Targeting Rankl Prevent Osteolysis and Enhance Chemotherapeutic Response in Osteosarcoma Models. Journal of Bone and Mineral Research, 26 (10). pp. 2452-2462. ISSN 0884-0431

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2011 American Society for Bone and Mineral Research
Keywords: RANKL; siRNAs; OSTEOCLASTOGENESIS INHIBITION; BITHERAPY
Dates:
  • Published: October 2011
  • Published (online): 28 June 2011
  • Accepted: 20 June 2011
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 09 May 2016 11:50
Last Modified: 09 May 2016 11:55
Published Version: http://dx.doi.org/10.1002/jbmr.455
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1002/jbmr.455
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics